Trials / Completed
CompletedNCT01128426
Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers
Postlicensure Observational Safety Study of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) Administered in Routine Use to Infants and Toddlers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 53,902 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 2 Months – 3 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to expand the understanding of the safety profile of 13vPnC in routine use following licensure and introduction of the vaccine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No Intervention |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2010-05-21
- Last updated
- 2014-07-14
- Results posted
- 2014-07-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01128426. Inclusion in this directory is not an endorsement.